Intellia Therapeutics (NTLA) P/S US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
P/S ? 253.6 0.00 0.00 19.9 14.4   28.1  
Changes by years, y/y, % +383% -100% -28%     -22.8%

Intellia Therapeutics. P/S

Intellia Therapeutics. P/S, changes, %

Intellia Therapeutics (NTLA) P/S US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
P/S ? 16.1 18.4 33.1 14.4 23.0   28.1
Changes by years, y/y, % -31% -30% +42%    
Changes by quarters, q/q, % -21% +14% +80% -56% +60%    

Intellia Therapeutics. P/S

Intellia Therapeutics. P/S, changes, y/y, %

Intellia Therapeutics. P/S, changes, q/q, %